Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Background:
Propolis is a natural resin made by bees from various plant sources. Propolis exerts
antimicrobial, anti-inflammatory, immunomodulatory, antioxidant, and antidiabetic properties.
The purpose of this study was to assess the adjunctive benefit of propolis supplementation in
individuals with both chronic periodontitis and type 2 diabetes mellitus (T2DM) receiving
scaling and root planing (SRP).
Methods:
A 6-month randomized blinded clinical trial comparing SRP with placebo (placebo+SRP group,
n=26) or combined with a 6- month regimen of 400 mg oral propolis once daily (propolis+SRP
group, n=26) was performed in patients with long-standing T2DM and chronic periodontitis.
Treatment outcomes included hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), serum
N€-(carboxymethyl) lysine (CML) and changes in periodontal parameters.